Your browser doesn't support javascript.
loading
Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors.
Dolivet, Enora; Gaichies, Léopold; Jeanne, Corinne; Bazille, Céline; Briand, Mélanie; Vernon, Mégane; Giffard, Florence; Leprêtre, Frédéric; Poulain, Laurent; Denoyelle, Christophe; Vigneron, Nicolas; Fauvet, Raffaèle.
Affiliation
  • Dolivet E; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.
  • Gaichies L; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.
  • Jeanne C; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.
  • Bazille C; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.
  • Briand M; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.
  • Vernon M; Department of Pathology, Caen University Hospital, F-14000 Caen, France.
  • Giffard F; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.
  • Leprêtre F; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.
  • Poulain L; Unicancer, Comprehensive Cancer Center F. Baclesse, Biological Ressources Centre OvaRessouces, F-14000 Caen, France.
  • Denoyelle C; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.
  • Vigneron N; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.
  • Fauvet R; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.
Int J Mol Sci ; 24(21)2023 Nov 06.
Article in En | MEDLINE | ID: mdl-37958997
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Precancerous Conditions / Neoplasms, Cystic, Mucinous, and Serous / Adenocarcinoma, Mucinous / MicroRNAs Limits: Female / Humans Language: En Journal: Int J Mol Sci Year: 2023 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Precancerous Conditions / Neoplasms, Cystic, Mucinous, and Serous / Adenocarcinoma, Mucinous / MicroRNAs Limits: Female / Humans Language: En Journal: Int J Mol Sci Year: 2023 Type: Article Affiliation country: France